Isogenic induced pluripotent stem cells (IPSCS) derived from mosaic hereditary hemorrhagic telangiectasia type 1 (HHT1) patient

  • V. V. Orlova
  • , X. Cao
  • , C. Freund
  • , G. Sanchez-Duffhues
  • , L. Hawinkels
  • , S. Petrus-Reurer
  • , F. E. van den Hil
  • , F. Disch
  • , R. J. Snijder
  • , C. J. J. Westermann
  • , J. J. Mager
  • , P. ten Dijke
  • , Ploos J. K. van Amstel
  • , C. L. Mummery

Research output: Contribution to journalMeeting AbstractAcademic

Abstract

SESSION 12 MECHANISMS OF HHT
Original languageEnglish
Pages (from-to)129-129
JournalAngiogenesis
Volume21
Issue number1
DOIs
Publication statusPublished - 1 Feb 2018
Externally publishedYes

Fingerprint

Dive into the research topics of 'Isogenic induced pluripotent stem cells (IPSCS) derived from mosaic hereditary hemorrhagic telangiectasia type 1 (HHT1) patient'. Together they form a unique fingerprint.

Cite this